BioWorld

July 31, 2007

View Archived Issues

Vivus Gains Evamist Approval, $140M Payment From Partner

Vivus Inc. won FDA approval of its Evamist product, triggering a $140 million milestone payment from a partnership entered earlier this year. (BioWorld Today) Read More

Plasma-Based Drug Firm Talecris Seeking $1B IPO

Read More

ImClone, BMS Pump Cash Into Erbitux For Broad Label

Read More

Alnylam, Medtronic Expand Deal With RNAi Drug-Device Combos

Read More

Other News To Note

Read More

Clinic Roundup

Read More